On the public citation graph

Fingerprint‐based computational models of 5‐lipo‐oxygenase activating protein inhibitors: Activity prediction and structure clustering

0 signed · 76 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cem.1296openalex-snapshot
Applicability domain for in silico models to achieve accuracy of experimental measurements
inferredcites →https://doi.org/10.1002/qsar.200810053openalex-snapshot
Molecular Docking and 3‐D QSAR Studies of Substituted 2,2‐Bisaryl‐Bicycloheptanes as Human 5‐Lipoxygenase‐Activating Protein (FLAP) Inhibitors
inferredcites →https://doi.org/10.1007/bf01976210openalex-snapshot
In vitro pharmacology of BAY X1005, a new inhibitor of leukotriene synthesis
inferredcites →https://doi.org/10.1007/s10044-013-0364-4openalex-snapshot
A clustering ensemble framework based on selection of fuzzy weighted clusters in a locally adaptive clustering algorithm
inferredcites →https://doi.org/10.1007/s10044-017-0676-xopenalex-snapshot
A comprehensive study of clustering ensemble weighting based on cluster quality and diversity
inferredcites →https://doi.org/10.1007/s10462-018-9642-2openalex-snapshot
Clustering ensemble selection considering quality and diversity
inferredcites →https://doi.org/10.1007/s10462-019-09701-yopenalex-snapshot
Diversity based cluster weighting in cluster ensemble: an information theory approach
inferredcites →https://doi.org/10.1007/s10479-011-0841-3openalex-snapshot
Multiobjective evolutionary algorithms to identify highly autocorrelated areas: the case of spatial distribution in financially compromised farms
inferredcites →https://doi.org/10.1007/s10994-010-5221-8openalex-snapshot
Dual coordinate descent methods for logistic regression and maximum entropy models
inferredcites →https://doi.org/10.1007/s11634-013-0130-xopenalex-snapshot
A clustering ensemble framework based on elite selection of weighted clusters
inferredcites →https://doi.org/10.1016/0167-8655(87)90072-9openalex-snapshot
A pattern recognition approach to understanding the multi-layer perception
inferredcites →https://doi.org/10.1016/j.bmc.2012.04.048openalex-snapshot
Identification of novel benzimidazole derivatives as inhibitors of leukotriene biosynthesis by virtual screening targeting 5-lipoxygenase-activating protein (FLAP)
inferredcites →https://doi.org/10.1016/j.bmcl.2005.05.027openalex-snapshot
Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886
inferredcites →https://doi.org/10.1016/j.bmcl.2008.01.105openalex-snapshot
Substituted 2,2-bisaryl-bicycloheptanes as novel and potent inhibitors of 5-lipoxygenase activating protein
inferredcites →https://doi.org/10.1016/j.bmcl.2009.10.131openalex-snapshot
5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)—A potent FLAP inhibitor
inferredcites →https://doi.org/10.1016/j.bmcl.2010.10.024openalex-snapshot
Potent and selective 5-LO inhibitor bearing benzothiophene pharmacophore: Discovery of MK-5286
inferredcites →https://doi.org/10.1016/j.bmcl.2012.04.064openalex-snapshot
Evaluation of endo- and exo-aryl-substitutions and central scaffold modifications on diphenyl substituted alkanes as 5-lipoxygenase activating protein inhibitors
inferredcites →https://doi.org/10.1016/j.bmcl.2017.05.001openalex-snapshot
QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM)
inferredcites →https://doi.org/10.1016/j.bmcl.2017.09.007openalex-snapshot
Discovery and optimization of oxadiazole-based FLAP inhibitors
inferredcites →https://doi.org/10.1016/j.chemolab.2017.01.010openalex-snapshot
How important is to detect systematic error in predictions and understand statistical applicability domain of QSAR models?
inferredcites →https://doi.org/10.1016/j.drudis.2006.10.005openalex-snapshot
Similarity-based virtual screening using 2D fingerprints
inferredcites →https://doi.org/10.1016/j.ejmech.2017.07.019openalex-snapshot
Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis
inferredcites →https://doi.org/10.1016/j.ejphar.2018.10.040openalex-snapshot
A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease
inferredcites →https://doi.org/10.1016/j.tips.2007.11.006openalex-snapshot
What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases
inferredcites →https://doi.org/10.1016/s0960-894x(00)80459-xopenalex-snapshot
Development of L-689,065 - the prototype of a new class of potent 5-lipoxygenase inhibitors
inferredcites →https://doi.org/10.1016/s0960-894x(00)80520-xopenalex-snapshot
A new class of leukotriene biosynthesis inhibitors: The discovery of MK0591
inferredcites →https://doi.org/10.1016/s0960-894x(99)00399-6openalex-snapshot
Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors
inferredcites →https://doi.org/10.1016/s1081-1206(10)61317-8openalex-snapshot
The role of leukotrienes in allergic rhinitis
inferredcites →https://doi.org/10.1021/acs.jcim.5b00110openalex-snapshot
The Relative Importance of Domain Applicability Metrics for Estimating Prediction Errors in QSAR Varies with Training Set Diversity
inferredcites →https://doi.org/10.1021/acs.jcim.7b00300openalex-snapshot
Identification of Novel Aurora Kinase A (AURKA) Inhibitors via Hierarchical Ligand-Based Virtual Screening
inferredcites →https://doi.org/10.1021/ci00054a008openalex-snapshot
Topological torsion: a new molecular descriptor for SAR applications. Comparison with other descriptors
inferredcites →https://doi.org/10.1021/ci010368vopenalex-snapshot
Prediction ofn-Octanol/Water Partition Coefficients from PHYSPROP Database Using Artificial Neural Networks and E-State Indices
inferredcites →https://doi.org/10.1021/ci049782wopenalex-snapshot
Similarity to Molecules in the Training Set Is a Good Discriminator for Prediction Accuracy in QSAR
inferredcites →https://doi.org/10.1021/ci050413popenalex-snapshot
QSAR − How Good Is It in Practice? Comparison of Descriptor Sets on an Unbiased Cross Section of Corporate Data Sets
inferredcites →https://doi.org/10.1021/ci100050topenalex-snapshot
Extended-Connectivity Fingerprints
inferredcites →https://doi.org/10.1021/ci100253ropenalex-snapshot
Applicability Domains for Classification Problems: Benchmarking of Distance to Models for Ames Mutagenicity Set
inferredcites →https://doi.org/10.1021/jm000180nopenalex-snapshot
Symmetrical Bis(heteroarylmethoxyphenyl)alkylcarboxylic Acids as Inhibitors of Leukotriene Biosynthesis
inferredcites →https://doi.org/10.1021/jm2008369openalex-snapshot
5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3- tert -Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1 H -indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor
inferredcites →https://doi.org/10.1021/jm501185jopenalex-snapshot
Synthesis, SAR, and Series Evolution of Novel Oxadiazole-Containing 5-Lipoxygenase Activating Protein Inhibitors: Discovery of 2-[4-(3-{(R)-1-[4-(2-Amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]-N,N-dimethyl-acetamide (BI 665915)
inferredcites →https://doi.org/10.1021/jm900945dopenalex-snapshot
5-Lipoxygenase-Activating Protein Inhibitors: Development of 3-[3-tert-Butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic Acid (AM103)
inferredcites →https://doi.org/10.1021/tx0341409openalex-snapshot
In Vitro Metabolism of 2-Acetylbenzothiophene: Relevance to Zileuton Hepatotoxicity
inferredcites →https://doi.org/10.1023/a:1010933404324openalex-snapshot
Random Forests
inferredcites →https://doi.org/10.1038/nrc2809openalex-snapshot
Eicosanoids and cancer
inferredcites →https://doi.org/10.1038/sj.bjp.0707416openalex-snapshot
The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5‐lipoxygenase products
inferredcites →https://doi.org/10.1038/srep42751openalex-snapshot
Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screening
inferredcites →https://doi.org/10.1039/c1mb05164dopenalex-snapshot
Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once?
inferredcites →https://doi.org/10.1042/cs20050012openalex-snapshot
Eicosanoids: mediators and therapeutic targets in fibrotic lung disease
inferredcites →https://doi.org/10.1046/j.1525-1381.1999.t01-1-99242.xopenalex-snapshot
Asthma Therapy with Agents Preventing Leukotriene Synthesis or Action
inferredcites →https://doi.org/10.1073/pnas.81.3.689openalex-snapshot
Enzyme with dual lipoxygenase activities catalyzes leukotriene A4 synthesis from arachidonic acid.
inferredcites →https://doi.org/10.1080/1062936x.2018.1513952openalex-snapshot
SAR and QSAR models of cyclooxygenase-1 (COX-1) inhibitors
inferredcites →https://doi.org/10.1080/13543776.2017.1276568openalex-snapshot
Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents
inferredcites →https://doi.org/10.1084/jem.185.6.1123openalex-snapshot
Collagen-induced Arthritis Is Reduced in 5-Lipoxygenase-activating Protein-deficient Mice
inferredcites →https://doi.org/10.1093/cvr/cvq016openalex-snapshot
The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease
inferredcites →https://doi.org/10.1093/nar/gkr777openalex-snapshot
ChEMBL: a large-scale bioactivity database for drug discovery
inferredcites →https://doi.org/10.1096/fj.201500210ropenalex-snapshot
5‐Lipoxygenase‐activating protein rescues activity of 5‐lipoxygenase mutations that delay nuclear membrane association and disrupt product formation
inferredcites →https://doi.org/10.1111/cts.12546openalex-snapshot
Initial Clinical Experience with AZD5718, a Novel Once Daily Oral 5‐Lipoxygenase Activating Protein Inhibitor
inferredcites →https://doi.org/10.1126/science.1144346openalex-snapshot
Crystal Structure of Inhibitor-Bound Human 5-Lipoxygenase-Activating Protein
inferredcites →https://doi.org/10.1136/ard.2009.127993openalex-snapshot
Relationship between bone marrow lesions, cartilage loss and pain in knee osteoarthritis: results from a randomised controlled clinical trial using MRI
inferredcites →https://doi.org/10.1139/y89-073openalex-snapshot
L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor
inferredcites →https://doi.org/10.1145/1961189.1961199openalex-snapshot
LIBSVM
inferredcites →https://doi.org/10.1186/1758-2946-5-26openalex-snapshot
Open-source platform to benchmark fingerprints for ligand-based virtual screening
inferredcites →https://doi.org/10.1186/1758-2946-6-10openalex-snapshot
Cross-validation pitfalls when selecting and assessing regression and classification models
inferredcites →https://doi.org/10.1517/14728222.2014.945425openalex-snapshot
Targeting 5-lipoxygenase-activating protein in asthma and chronic obstructive pulmonary disease
inferredcites →https://doi.org/10.2174/157018011793663903openalex-snapshot
QSAR Study on 5-Lipoxygenase Activating Protein (FLAP) Inhibitors: The Derivatives of 2,2-Bisaryl-Bicycloheptane
inferredcites →https://doi.org/10.2174/187152809789352177openalex-snapshot
Targeting Leukotrienes for the Treatment of COPD?
inferredcites →https://doi.org/10.48550/arxiv.1201.0490openalex-snapshot
Scikit-learn: Machine Learning in Python

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1007/s10953-025-01509-5openalex-snapshot
Inter-HVI: Bridging Interpretability and Accuracy in Hypervalent Iodine Reactivity Prediction
inferred← citeshttps://doi.org/10.1007/s11030-022-10466-wopenalex-snapshot
Classification models and SAR analysis on HDAC1 inhibitors using machine learning methods
inferred← citeshttps://doi.org/10.1007/s11030-023-10649-zopenalex-snapshot
A consensual machine-learning-assisted QSAR model for effective bioactivity prediction of xanthine oxidase inhibitors using molecular fingerprints
inferred← citeshttps://doi.org/10.1016/j.jhazmat.2025.141018openalex-snapshot
BeeMSAI: A multi-dimensional evaluation strategy for honeybee toxicity in agrochemicals integrating mode of action, structural analysis, and AI–powered prediction
inferred← citeshttps://doi.org/10.1021/acs.chemrestox.2c00330openalex-snapshot
Prediction and Structure–Activity Relationship Analysis on Ready Biodegradability of Chemical Using Machine Learning Method
inferred← citeshttps://doi.org/10.1021/acs.jcim.3c01280openalex-snapshot
Attention Mechanism-Based Graph Neural Network Model for Effective Activity Prediction of SARS-CoV-2 Main Protease Inhibitors: Application to Drug Repurposing as Potential COVID-19 Therapy
inferred← citeshttps://doi.org/10.1080/1062936x.2022.2078880openalex-snapshot
Classification models and SAR analysis on thromboxane A2 synthase inhibitors by machine learning methods
inferred← citeshttps://doi.org/10.1097/ms9.0000000000002240openalex-snapshot
Chemical burn wounds as a risk factor for gastric cancer: in-silico analyses—experimental research
inferred← citeshttps://doi.org/10.1186/s12911-025-03041-4openalex-snapshot
Ensemble techniques for predictive modeling of leishmanial activity via molecular fingerprints
inferred← citeshttps://doi.org/10.3389/fphar.2022.825741openalex-snapshot
Combined Machine Learning and GRID-Independent Molecular Descriptor (GRIND) Models to Probe the Activity Profiles of 5-Lipoxygenase Activating Protein Inhibitors
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.